Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is the classic progressive fibrosing interstitial lung disease (ILD), but some patients with ILDs other than IPF also develop a progressive fibrosing phenotype (PF-ILD). Information on use and cost of healthcare resources in patients with PF-ILD is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Amy L., Maher, Toby M., Acciai, Valentina, Mounir, Baher, Quaresma, Manuel, Zouad-Lejour, Leila, Wells, Christopher D., De Loureiro, Lou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467408/
https://www.ncbi.nlm.nih.gov/pubmed/32451950
http://dx.doi.org/10.1007/s12325-020-01380-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467408/
https://www.ncbi.nlm.nih.gov/pubmed/32451950
http://dx.doi.org/10.1007/s12325-020-01380-4

Ejemplares similares